F-star Therapeutics
- Pharmaceutical Preparations
- Cambridge, United Kingdom
Compensation history
Top executives at F-star Therapeutics received an average of $1M per person in annual compensation from 2015 to 2021.
By year
- 2020
EF$5MEliot ForsterPresident and Chief Executive OfficerNB$2MNeil BrewisChief Scientific OfficerND$2MNeil Brewis, PhD., DScChief Scientific OfficerLK$1MLouis KayitalireChief Medical OfficerDD$983KDarlene Deptula-HicksChief Financial Officer and TreasurerRI$842KR.P. Kris IyerFormer Chief Scientific OfficerMD$688KMartin DriscollFormer Chief Executive OfficerJF$230KJonathan FreveFormer Chief Financial Officer and Treasurer- 2019
EF$2MEliot ForsterPresident and Chief Executive OfficerMD$1MMartin DriscollFormer Chief Executive OfficerJF$988KJonathan FreveFormer Chief Financial Officer and TreasurerRI$886KR.P. Kris IyerFormer Chief Scientific OfficerDD$870KDarlene Deptula-HicksChief Financial Officer and TreasurerLK$740KLouis KayitalireChief Medical OfficerNB$500KNeil BrewisChief Scientific Officer
Executives
We found ten executives who work or worked at F-star Therapeutics.
Eliot Forster
F-star Therapeutics
Chief Executive Officer
Darlene Deptula-Hicks
F-star Therapeutics
Chief Financial Officer
Louis Kayitalire
F-star Therapeutics
Chief Medical Officer
Neil DSc
F-star Therapeutics
Chief Scientific Officer
Neil Brewis
F-star Therapeutics
Chief Scientific Officer
RP Iyer
F-star Therapeutics
Chief Scientific Officer
Martin Driscoll
F-star Therapeutics
Chief Executive Officer
Jonathan Freve
F-star Therapeutics
Chief Financial Officer
News
About F-star Therapeutics
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 35 Parkwood Drive, Babraham Research Campus, Cambridge, United Kingdom CB22 3AT
- 44 1223 497400
- December 31
- Former names
- Spring Bank Pharmaceuticals, Inc.